Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells

Endocrine-Related Cancer

Volumn 18, Issue 6, 2011, Pages 687-697

  Hou, Peng ^a   Liu, Dingxie ^a   Xing, Mingzhao ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; HIGH MOBILITY GROUP B2 PROTEIN; SHORT HAIRPIN RNA;

ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA;

AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENOME, HUMAN; GLUTAMIC ACID; HUMANS; MICROARRAY ANALYSIS; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; VALINE;

EID: 84862909154     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0212     Document Type: Article

References (25)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, et al. (eds) 2010. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute: Bethesda, MD, USA, http://seer.cancer.gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site.
2. Ang PW, Li WQ, Soong R & Iacopetta B 2009 BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients. Cancer Letters 273 221-224. (doi:10.1016/j.canlet.2008.08.001)
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W et al. 2002 Mutations of the BRAF gene in human cancer. Nature 417 949-954. (doi:10.1038/nature00766)
4. Estécio MR, Yan PS, Ibrahim AE, Tellez CS, Shen L, Huang TH & Issa JP 2007 High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Research 17 1529-1536. (doi:10.1101/gr.6417007)
5. Hattermann K, Mehdorn HM, Mentlein R, Schultka S & Held-Feindt J 2008 A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Analytical Biochemistry 377 62-71. (doi:10.1016/j.ab.2008. 03.014)
6. Heisler LE, Torti D, Boutros PC, Watson J, Chan C, Winegarden N, Takahashi M, Yau P, Huang TH, Farnham PJ et al. 2005 CpG island microarray probe sequences derived from a physical library are representative of CpG islands annotated on the human genome. Nucleic Acids Research 33 2952-2961. (doi:10.1093/nar/gki582)
7. Hou P, Ji M & Xing M 2008 Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors. Cancer 113 2440-2447. (doi:10.1002/cncr.23869)
8. Hsiao SH, Huang TH & Leu YW 2009 Excavating relics of DNA methylation changes during the development of neoplasia. Seminars in Cancer Biology 19 198-208. (doi:10.1016/j.semcancer.2009.02.015)
9. Hu S, Liu D, Tufano RP, Carson KA, Rosenbaum E, Cohen Y, Holt EH, Kiseljak-Vassiliades K, Rhoden KJ, Tolaney S et al. 2006 Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. International Journal of Cancer 119 2322-2329. (doi:10.1002/ijc.22110)
10. Hundahl SA, Fleming ID, Fremgen AM & Menck HR 1998 A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83 2638-2648. (doi:10.1002/(SICI)1097-0142(19981215)83: 12〈2638::AID-CNCR31〉3.0.CO;2-1)
11. Jones PA & Baylin SB 2007 The epigenomics of cancer. Cell 128 683-692. (doi:10.1016/j.cell.2007.01.029)
12. Kondo Y & Issa JP 2010 DNA methylation profiling in cancer. Expert Reviews in Molecular Medicine 12 e23. (doi:10.1017/S1462399410001559)
13. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 402-408. (doi:10.1006/meth.2001.1262)
14. Maddodi N, Bhat KM, Devi S, Zhang SC & Setaluri V 2010 Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1. Journal of Biological Chemistry 285 242-254. (doi:10.1074/jbc.M109.068668)
15. Nikiforov YE 2008 Thyroid carcinoma: molecular pathways and therapeutic targets. Modern Pathology 21 (Suppl 2) S37-S43. (doi:10.1038/modpathol.2008.10)
16. Shalev SA, Chervinski E, Weiner E, Mazor G, Friez MJ & Schwartz CE 2006 Clinical variation of Aarskog syndrome in a large family with 2189delA in the FGD1 gene. American Journal of Medical Genetics. Part A 140 162-165. (doi:10.1002/ajmg.a.31033)
17. Shi H, Yan PS, Chen CM, Rahmatpanah F, Lofton-Day C, Caldwell CW & Huang TH 2002 Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Research 62 3214-3220. (Pubitemid 34602416)
18. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB & Issa JP 1999 Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Research 59 2307-2312. (Pubitemid 29242273)
19. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D et al. 2006 CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genetics 38 787-793. (doi:10.1038/ng1834)
20. Whitehead IP, Abe K, Gorski JL & Der CJ 1998 CDC42 and FGD1 cause distinct signaling and transforming activities. Molecular and Cellular Biology 18 4689-4697. (Pubitemid 28343054)
21. Xing M 2005 BRAF mutation in thyroid cancer. Endocrine-Related Cancer 12 245-262. (doi:10.1677/erc.1.0978)
22. Xing M 2007a BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocrine Reviews 28 742-762. (doi:10.1210/er.2007-0007)
23. Xing M 2007b Gene methylation in thyroid tumorigenesis. Endocrinology 148 948-953. (doi:10.1210/en.2006-0927)
24. Yamada S & Maruyama I 2007 HMGB1, a novel inflammatory cytokine. Clinica Chimica Acta 375 36-42. (doi:10.1016/j.cca.2006.07.019)
25. Yan PS, Chen CM, Shi H, Rahmatpanah F, Wei SH, Caldwell CW & Huang TH 2001 Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Research 61 8375-8380. (Pubitemid 33131108)